* Aethlon Medical Inc AEMD.OQ AEMD.O is expected to show
no
change in quarterly revenue when it reports results on February
14 for the period ending December 31 2023
*
* LSEG's mean analyst estimate for Aethlon Medical Inc is
for a
loss of $1.23 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $40.00, above its last closing price of $1.75.
This summary was machine generated February 13 at 00:43 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)